background
human
influenza
viru
hemagglutinin
prefer
use
sialic
acid
sa
receptor
via
linkag
protein
encod
gene
respons
addit
link
sa
disaccharid
glycan
glycoprotein
found
cellular
surfac
therefor
could
potenti
target
antiinfluenza
therapeut
use
specif
small
interf
rna
sirna
block
express
limit
distribut
sa
receptor
surfac
airway
epitheli
cell
result
sirna
duplex
use
inhibit
mrna
express
subsequ
express
encod
protein
result
synthesi
sa
galactos
inhibit
adsorpt
influenza
viru
particl
surfac
cell
transfect
appropri
specif
sirna
significantli
reduc
intracellular
viral
genom
copi
number
viru
titer
within
supernat
cell
transfect
sirna
significantli
reduc
dosedepend
manner
compar
untransfect
cell
cell
transfect
nonspecif
sirna
conclus
use
sirna
target
inhibit
express
certain
cell
surfac
receptor
therebi
prevent
viru
adsorpt
result
inhibit
human
influenza
viru
infect
find
signific
develop
identif
potenti
new
antiinfluenza
drug
target
influenza
viru
infect
consid
signific
public
health
problem
given
caus
season
epidem
recur
pandem
case
infect
human
death
attribut
global
influenza
pandem
high
mutat
rate
viral
genom
vaccin
drug
initi
direct
viru
often
becom
ineffect
therefor
measur
urgent
need
prevent
treat
influenza
viru
infect
especi
highrisk
group
event
anoth
pandem
certain
host
cell
factor
involv
viral
infect
cycl
attract
interest
therapeut
target
crucial
viral
infect
target
factor
might
inhibit
infect
ad
advantag
less
prone
mutat
sialic
acid
sa
molecul
found
nonreduc
termin
posit
glycoprotein
glycolipid
surfac
cell
bind
target
influenza
viru
iav
hemagglutinin
human
iav
preferenti
bind
link
sa
abundantli
express
human
respiratori
tract
ha
protein
avian
iav
prefer
link
sa
receptor
predomin
avian
enter
tract
bind
ha
appropri
receptor
crucial
initi
infect
therefor
serv
potenti
therapeut
target
novel
sialidas
fusion
protein
fludas
enzymat
remov
sa
respiratori
epithelium
exhibit
potent
antivir
activ
influenza
b
virus
sialyltransferas
key
enzym
regul
biosynthesi
sialyl
oligosaccharid
sequenc
weinstein
et
al
conclud
one
enzym
encod
respons
addit
sa
disaccharid
found
glycan
nlink
olink
glycoprotein
lin
et
al
found
antisenseoligodeoxynucleotid
target
mrna
could
inhibit
enzymat
activ
reduc
cell
surfac
numer
studi
involv
small
interf
rna
sirna
treatment
viral
infect
conduct
includ
success
applic
sirna
treat
sever
acut
respiratori
syndrom
sar
infect
rhesu
macaqu
qe
et
al
use
sirna
specif
conserv
region
influenza
viru
genom
prove
potent
inhibitor
influenza
viru
replic
vitro
vivo
howev
sirna
sole
target
gene
influenza
virus
unlik
suffici
elimin
infect
high
possibl
gener
resist
mutant
therefor
sirna
target
host
cellular
determin
crucial
viral
entri
andor
replic
could
efficaci
antivir
therapi
studi
design
evalu
sirna
target
airway
epitheli
cell
design
four
sirna
duplex
screen
abil
downregul
express
affect
biosynthesi
sa
human
respiratori
tract
epithelium
antivir
effect
select
sirna
duplex
demonstr
use
viral
bind
assay
determin
cytoplasm
viral
genom
copi
number
viru
titer
cultur
supernat
express
sirnatransfect
hbe
respiratori
epitheli
cell
use
qpcr
assay
determin
reduct
mrna
express
level
h
posttransfect
figur
b
potent
sirna
candid
effect
verifi
use
western
blot
assay
cell
transfect
select
sirna
express
substanti
lower
transfect
control
sirna
untransfect
cell
figur
roughli
correspond
reduct
mrna
level
observ
qpcr
concentr
sirna
use
nm
advers
affect
number
viabl
cell
affect
cell
morpholog
data
shown
hbe
cell
figur
addit
file
figur
use
sirna
nm
cytotox
observ
base
result
use
sirna
nm
remaind
experi
express
receptor
observ
surfac
cultur
human
cell
figur
treatment
sirna
significantli
reduc
number
receptor
cell
surfac
figur
compar
control
sirna
figur
untransfect
cell
figur
similar
result
seen
hbe
cell
addit
file
figur
fac
analysi
cell
reveal
sirnatransduc
cell
decreas
express
cell
treat
control
sirna
untreat
cell
display
normal
level
express
figur
viru
strain
test
bound
crbc
express
sa
viru
preferenti
bound
crbc
wherea
human
season
human
influenza
viru
preferenti
bound
crbc
figur
reduct
viral
yield
seen
sirnatransduc
cell
challeng
strain
compar
control
cell
figur
b
similar
result
observ
hbe
cell
addit
file
figur
differ
observ
cell
infect
avian
viru
figur
viru
particl
abund
surfac
cell
transfect
control
sirna
infect
virus
figur
b
howev
reduct
number
bound
viru
particl
cell
treat
sirna
figur
genom
copi
number
virus
reduc
follow
transfect
variou
cell
line
hbe
sirna
figur
prior
viral
infect
express
supernat
sirnatransfect
cell
line
hbe
detect
posit
control
long
doublestrand
rna
known
induc
express
includ
figur
studi
abl
demonstr
downregul
major
influenza
receptor
respiratori
epitheli
cell
promis
approach
prevent
viral
entri
establish
infect
human
influenza
infect
caus
viru
strain
transmit
via
airborn
rout
human
respiratori
tract
although
report
avian
influenza
virus
directli
infect
human
design
sirna
target
attempt
inhibit
viru
infect
hbe
cell
repres
upper
middl
lower
respiratori
tract
epitheli
cell
respect
without
induc
interferon
respons
treatment
sirna
depend
upon
function
immun
system
therefor
sirna
therapi
could
effect
elderli
immunocompromis
individu
immunocompet
individu
sirna
target
use
current
studi
could
ideal
prevent
influenza
infect
patient
group
low
immun
result
pertain
viru
bind
indic
sirna
reduc
number
iav
virion
attach
epitheli
cell
reduc
express
cell
surfac
recent
studi
suggest
sirna
could
side
effect
advers
affect
cell
viabil
demonstr
effect
dose
nm
sirna
condit
test
toxic
respiratori
epitheli
cell
vitro
howev
notic
express
level
receptor
substanti
diminish
result
sirna
target
influenza
virus
natur
infect
epitheli
cell
upper
respiratori
tract
lung
human
thu
sirna
administ
inhal
would
result
much
higher
local
sirna
concentr
could
achiev
parenter
inject
without
advers
affect
epitheli
cell
studi
focus
aspect
current
underway
laboratori
studi
investig
found
human
influenza
virus
still
infect
knockout
mice
achiev
similar
titer
lung
trachea
compar
wildtyp
anim
possibl
explan
greater
effici
infect
result
defici
system
influenzaspecif
humor
respons
knockout
mice
two
major
type
differ
penultim
bond
synthes
differ
enzym
human
influenza
viru
strain
propag
allanto
caviti
abl
bind
recombin
rat
use
reconstitut
sialic
acid
one
type
galactos
link
glycan
linkag
howev
possibl
strain
maintain
abil
bind
thu
present
mice
compens
loss
monteerarat
et
al
report
suppress
express
sirna
anoth
sialyltransferas
could
inhibit
avian
influenza
viru
infect
find
current
studi
support
conclus
monteerarat
et
al
extend
airway
epitheli
target
human
iav
infect
combin
two
type
sirna
might
result
broader
spectrum
synergist
activ
depend
upon
target
nontarget
sirna
demonstr
vitro
efficaci
sirna
target
respiratori
epitheli
cell
prevent
iav
infect
viru
entri
stage
vivo
preclin
test
requir
determin
suitabl
sirna
use
human
use
madindarbi
canin
kidney
mdck
cell
viru
propag
tissu
cultureinfect
dose
tcid
titrat
assay
mdck
cell
minim
essenti
medium
mem
gibco
carlsbad
ca
usa
normal
control
nontarget
sirna
sirna
design
use
rnai
design
synthes
invitrogen
invitrogen
carlsbad
ca
usa
sequenc
avail
addit
file
tabl
neg
control
use
nontarget
sirna
qiagen
valencia
ca
usa
sirna
duplex
doublestrand
rna
molecul
compris
nt
dtdt
overhang
end
target
sequenc
subject
basic
local
align
search
tool
blast
search
genbank
ensur
uniqu
airway
epitheli
cell
line
hbe
transfect
either
nontarget
sirna
use
rnaimax
invitrogen
accord
manufactur
instruct
differ
time
point
posttransfect
cell
either
infect
influenza
viru
harvest
downstream
experi
express
detect
use
realtim
revers
transcript
polymeras
chain
reaction
qpcr
assay
express
protein
determin
western
blot
respiratori
epitheli
cell
hbe
transfect
control
sirna
nmol
h
posttransfect
use
rneasi
mini
kit
qiagen
rna
extract
accord
manufactur
instruct
extract
total
rna
ngsampl
use
cdna
synthesi
result
cdna
amplifi
reaction
contain
forward
revers
primer
addit
file
tabl
power
sybr
green
pcr
master
mix
appli
biosystem
foster
citi
ca
usa
reaction
subject
thermal
cycl
system
biorad
hercul
ca
usa
involv
initi
denatur
step
follow
cycl
fluoresc
signal
reaction
captur
end
extens
step
cycl
determin
specif
assay
amplicon
subject
melt
curv
analysi
cycl
data
analyz
use
method
accord
manufactur
instruct
express
level
normal
mrna
level
cultur
cell
logarithm
growth
phase
trypsin
seed
plate
transfect
nmol
control
nmol
sirna
h
posttransfect
cell
viabil
determin
use
bromid
mtt
assay
sigmaaldrich
absorb
nm
measur
spectrophotomet
molecular
devic
palo
alto
ca
usa
background
valu
subtract
averag
absorb
valu
obtain
sirna
treatment
compar
valu
obtain
sirna
absent
viabil
assay
perform
duplic
least
four
well
detect
link
sa
cell
surfac
hbe
cell
treat
control
sirna
cultur
h
cell
wash
phosphatebuff
salin
pb
fix
formaldehyd
pb
min
detect
sialic
acid
residu
surfac
cell
apic
monolay
block
bovin
serum
albumin
bsa
merck
darmstadt
germani
pb
min
incub
fluorescein
isothiocyan
fitc
conjug
sambucu
nigra
lectin
sna
vector
laboratori
burlingam
ca
usa
h
confirm
specif
lectin
bind
monolay
treat
mu
vibrio
cholera
neuraminidas
vcna
roch
almer
netherland
h
prior
fixat
examin
rapidscan
confoc
laser
microscop
nikon
corp
tokyo
japan
approxim
cell
transfect
control
sirna
scrape
cultur
surfac
wash
twice
pb
contain
mm
glycin
wash
buffer
mm
trishcl
nacl
mm
mgcl
mm
mncl
mm
cacl
ph
cell
block
bsapb
h
ice
wash
manner
describ
centrifug
cell
pellet
incub
fitcconjug
sna
room
temperatur
min
wash
fix
paraformaldehyd
anoth
three
wash
pb
mean
fluoresc
intens
determin
fluorescenceactiv
cell
sorter
fac
calibur
flow
cytomet
bd
san
jose
ca
usa
count
minimum
event
studi
receptorbind
properti
viru
strain
use
enzymat
modifi
chicken
red
blood
cell
crbc
express
either
sialic
acid
sa
gal
previous
describ
minor
modif
briefli
sa
remov
crbc
use
mu
vcna
h
subsequ
resialyl
perform
use
mu
n
sialyltransferas
calbiochem
la
jolla
ca
usa
mu
n
sialyltransferas
japan
tobacco
shizuoka
japan
mm
cytidin
monophosphonacetylneuramin
cmp
sialic
acid
sigmaaldrich
min
respect
receptor
specif
viru
strain
determin
use
standard
hemagglutin
assay
modifi
crbc
influenza
viru
challeng
transduc
epitheli
cell
challeng
experi
carri
multipl
infect
moi
h
presenc
nptosyllphenylalanin
chloromethyl
keton
tpck
trypsin
sigmaaldrich
viral
supernat
harvest
variou
time
point
postinfect
tcid
assay
obtain
doserespons
curv
dilut
seri
sirna
ad
cell
plate
triplic
cell
challeng
supernat
examin
describ
titer
virus
supernat
determin
use
tcid
assay
previous
describ
briefli
mdck
cell
seed
onto
flatbottom
plate
cellswel
h
later
serumcontain
medium
remov
viruscontain
supernat
serial
dilut
tenfold
ad
well
triplic
incub
h
infect
medium
contain
tpcktrypsin
ad
well
incub
h
presenc
absenc
viru
cultur
supernat
determin
hemagglutin
crbc
viru
titer
determin
interpol
dilut
endpoint
infect
well
viru
titer
present
log
tcid
cell
transfect
control
sirna
infect
viru
moi
chill
min
infect
cell
harvest
wash
three
time
pb
fix
glutaraldehyd
min
room
temperatur
postfix
osmium
tetroxid
fix
cell
dehydr
increas
concentr
aceton
embed
epoxi
resin
polymer
conduct
h
ultrathin
section
stain
uranyl
acet
lead
citrat
section
view
photograph
hitachi
transmiss
electron
microscop
hitachi
co
tokyo
japan
extract
rna
h
viru
infect
use
qiaamp
rna
isol
kit
qiagen
firststrand
cdna
synthes
use
rnase
h
revers
transcriptas
invitrogen
random
primer
use
cdna
qpcr
assay
along
primer
addit
file
tabl
fluoresc
probe
master
mix
appli
biosystem
sampl
subject
thermal
cycl
system
biorad
hercul
ca
usa
min
cycl
express
level
viral
rna
normal
constitut
express
ribonucleoprotein
measur
conduct
three
time
statist
analysi
hbe
cell
transfect
either
control
sirna
nm
measur
level
cultur
supernat
h
later
use
enzymelink
immunosorb
assay
elisa
pbl
biomed
laboratori
piscataway
nj
usa
long
doublestrand
rna
induc
express
use
posit
control
